ℹ️
🇬🇧
Search
Search for publications relevant for "HER2 positive"
HER2 positive
Publication
Class
Person
Publication
Programmes
publication
Experience in the treatment of advanced HER2 positive breast tumor in University Hospital in Motol
2016 |
Publication without faculty affiliation
publication
The current location of trastuzumab in the treatment of HER2 positive breast cancer
2009 |
First Faculty of Medicine
publication
Trastuzumab deruxtecan: strong player in the field of metastatic HER2 positive breast cancer
2022 |
First Faculty of Medicine
publication
Complete and long-term response of HER2 positive locally highly advanced metastatic breast cancer - case report
2019 |
Third Faculty of Medicine
publication
Neratinib in the context of an early breast cancer anti-HER2 therapy
2020 |
First Faculty of Medicine
publication
Management of HER2-positive breast cancer, escalation and de-escalation of the therapy
2017 |
First Faculty of Medicine
publication
Is there a benefit of HER2-positive breast cancer subtype determination in clinical practice?
2019 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Impact of Hormone Receptor Status on the Behaviour of HER2+ Breast Cancer
2020 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
publication
Personalization of neo/adjuvant treatment of HER2-positive breast cancer is the key to achieve the best results
2022 |
First Faculty of Medicine
publication
What is new in histopathology of breast carcinoma
2010 |
Faculty of Medicine in Hradec Králové
publication
Report of University Hospital Hradec Králové to the clinical trial protocol No: BO28407
Publication without faculty affiliation
publication
Breast Cancer in Young Women - Lessons from an Institutional Review
2014 |
Faculty of Medicine in Hradec Králové
publication
The importance of dual HER2 blockade in early HER2-positive breast cancer
2023 |
First Faculty of Medicine
publication
Review of tumor infiltrating lymphocytes assessment in breast cancer in routine diagnostic practice
2021 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
publication
Predictive diagnosis of breast cancer
2011 |
Faculty of Medicine in Hradec Králové
publication
Trastuzumab emtansine in the treatment of residual HER2-positive breast cancer
2019 |
First Faculty of Medicine
publication
News in anti-HER2 targeted therapy in breast cancer
2013 |
First Faculty of Medicine
publication
Advanced breast carcinoma. Is it an indication for bevacizumab use?
2015 |
First Faculty of Medicine
publication
Neoadjuvant treatment of early breast cancer
2019 |
Publication without faculty affiliation
publication
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - Results of the eLEcTRA trial
2012 |
First Faculty of Medicine
publication
New classification of breast tumors and lesions, their hormonal sensitivity a and our possibilities of prevention
2015 |
Publication without faculty affiliation
publication
Controversies of radiotherapy in human epidermal growth factor receptor (HER)-2 positive breast cancer patients
2021 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy
2014 |
First Faculty of Medicine
publication
Circulating tumor cells and serum levels of MMP-2, MMP-9 and VEGF as markers of the metastatic process in patients with high risk of metastatic progression
2017 |
First Faculty of Medicine
publication
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients
2017 |
Publication without faculty affiliation
publication
Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease
2020 |
Faculty of Medicine in Pilsen
publication
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer
2009 |
Third Faculty of Medicine
publication
Predictive diagnosis in breast cancer - What's new in 2018?
2018 |
Faculty of Medicine in Hradec Králové